Literature DB >> 1185250

Long-term survival of patients treated with BCNU for brain tumors.

J Calogero, D C Crafts, C B Wilson, E B Boldrey, A Rosenberg, K J Enot.   

Abstract

The authors present three patients who, after excision and irradiation of their brain tumors, were treated with BCNU for recurrence. All three patients responded well and now are without evidence of tumor, 37, 30, and 36 months after BCNU was stopped. Although these patients represent only a small fraction of those treated with BCNU, they indicate the potential role of chemotherapy in the management of glial tumors.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1185250     DOI: 10.3171/jns.1975.43.2.0191

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  4 in total

1.  Combined chemotherapy with VM 26 and BCNU for recurrent malignant gliomas after operation and irradiation.

Authors:  E Zander; N de Tribolet; L Wagenknecht
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

2.  Chemotherapy of malignant gliomas: comparison of the effect of polychemo- and CCNU-therapy.

Authors:  W D Heiss
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

3.  Morphological changes in anaplastic gliomas treated with radiation and chemotherapy.

Authors:  L Gerstner; K Jellinger; W D Heiss; G Wöber
Journal:  Acta Neurochir (Wien)       Date:  1977       Impact factor: 2.216

4.  Diagnosis of intracranial space-occupying lesions with DTPA-Sn-99mTc.

Authors:  V Calatayud-Maldonado; J Banzo-Marraco; M Uriguen-Saiz; J Teijeiro-Vidal; S Gonzalez-Arias; J L Carreras; J Redondo-Marco
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.